|
|
 |
|
 
| |
|
| ISIN: |
DE0005880405 |
| SCN: |
588040 |
| Trading segment: |
General Standard |
| Stock exchange: |
Frankfurt |
| Financial syndicate: |
Lead-managed:
Sal. Oppenheim jr. & Cie KGaA |
| Stock exchange identifier: |
GIR |
| First quotation: |
May 16, 2000 |
| Subscription price: |
20 EUR |
| Nominal value: |
1 EUR |
| Shareholder structure |
| Solvay Organics GmbH: | | 82% |
| Free-float: | | 18% |
|
| Capital stock after flotation: |
10.4 Mill. EUR |
| End of the business year: |
31st of December |
| Management Board: |
| Finance & Marketing: | | Martin Weiland (Speaker) |
| Legal Affairs and HR: | | Dr. Harald Mothes |
|
| Supervisory Board: |
| Chairman: | | Dr. Frank Schneider |
| Deputy Chairman: | | Dr. Jörg Kruse |
| Member: | | Dr. Ernest Alderson Edmonds |
|
| Address: |
Girindus AG
Buchenallee 20
51402 Bensberg, Germany |
| Internet: |
www.girindus.com |
| Contact: |
Head of Investor Relations & Corporate Communications
Markus Georgi
Telefon: +49 2204 926900
Telefax: +49 2204 926990
eMail: mgeorgi@girindus.com |
|
2009
Mill. EUR |
2008
Mill. EUR |
2007
Mill. EUR |
2006
Mill. EUR |
2005
Mill. EUR |
| Revenues |
10,4 |
22,8 |
21,8 |
21,6 |
29,4 |
| EBITDA |
-6,1 |
-14,2 |
-7,1 |
-5,6 |
-4,1 |
| EBIT |
-6,2 |
-16,9 |
-9,5 |
-7,8 |
-6,8 |
| Earnings per share (in EUR) |
-1.04 |
-2.80 |
-1.88 |
-1.31 |
-1.16 |
| Share capital (in EUR) |
7,043,772 |
6,500,000 |
6,500,000 |
6,500,000 |
6,500,000 |
| Stockholders' equity as of Dec. 31 |
-6,8 |
-6,8 |
11,1 |
10,0 |
19,1 |
| Equity to assets (%) |
-36.2 |
-42.8 |
36.7 |
28.8 |
56.7 |
| Number of employees as of Dec. 31 |
70 |
74 |
150 |
159 |
164 |
back to top
|
|
|
|
|
|
